SHOWCASING THE FUTURE OF CLEANROOM INNOVATION FOR THE LIFE SCIENCES AND ADVANCED TECHNOLOGY INDUSTRIES
CONSHOHOCKEN, Pa., July 24, 2025 /PRNewswire/ — GCS, a leading provider of modular cleanroom systems, today announced the grand opening of its new showroom in Conshohocken, Pennsylvania. This dedicated space offers pharmaceutical, biotech, and advanced technology manufacturing professionals the opportunity to experience firsthand the quality, flexibility, and performance of GCS state-of-the-art modular cleanroom solutions.
The new showroom highlights GCS cleanroom systems manufactured in North America to meet the growing demand for scalable, sustainable, and rapidly deployable cleanroom infrastructure. Visitors can walk through a full-scale installation, explore material and design options, and consult with technical experts to better understand how modular solutions can streamline cleanroom construction.
“We are excited to bring our modular cleanroom technology closer to our customers,” said Philippe Calland, President of GCS. “This showroom is more than just a display—it’s a resource for companies navigating the complex demands of critical controlled environments, offering a firsthand look at the future of cleanroom construction.”
The Conshohocken location will serve as an East Coast hub for product demonstrations, training, and collaboration with architects, engineers, and project stakeholders involved in controlled environment construction.
About GCS
GCS is the leading manufacturer of cleanroom doors, panels and ceilings for the Life Science, Pharmaceutical and Advanced Technology industries. GCS began manufacturing cleanroom products in 1978 as Panelco/Plasteurop, which was acquired by Summa Equity/G-CON in 2022. Today, GCS has manufacturing locations in the US and France and continues to develop new and innovative products for its comprehensive modular cleanroom portfolio.
https://www.gconbio.com/gcs-modular-cleanroom-systems/
SOURCE G-CON Manufacturing
NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…
"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…
WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…